Floatz logo

MALTOSE MONOHYDRATE

Bipolar Depression

Consorcio Centro de Investigación Biomédica en Red (CIBER)Small moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
81/ 100

Competitive context

29 Active assets in the Bipolar Depression cohort.

Asset / SponsorPhaseRating
Lurasidone
NeuroRx, Inc.
Phase 4A
LITHIUM, ELEMENTAL
Dr. Inge Winter
Phase 4BBB
Seroquel®
Dr. Inge Winter
Phase 4BBB
LAMOTRIGINE
Stony Brook University
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Joshua Rosenblat
Phase 4BBB

View all 50 →

Same molecule, other indications

MALTOSE MONOHYDRATE is also rated in:

bipolar disorderDormant
B
Indicative ·
57 / 100
View asset →
neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →
cancerDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →